PS-Liposome and Ox-LDL bind to different sites of the immunodominant domain (#155-183) of CD36: A study with GS95, a new anti-CD36 monoclonal antibody

Thrombosis Research

Volumn 97, Issue 5, 2000, Pages 317-326

  Yamaguchi, Atsumi ^a   Yamamoto, Naomasa ^a   Akamatsu, Noriko ^a   Saido, Takaomi C ^b   Kaneda, Mizuho ^a   Umeda, Masato ^a   Tanoue, Kenjiro ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

CD36; GS95 (anti CD36 monoclonal antibody); Oxidized LDL; phosphatidylserine liposome

Indexed keywords

CD36 ANTIGEN; EPITOPE; LIPOSOME; MONOCLONAL ANTIBODY CD 36; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; THIETHYLPERAZINE MALEATE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD36; BINDING, COMPETITIVE; BLOOD PLATELETS; FLOW CYTOMETRY; HUMANS; IMMUNODOMINANT EPITOPES; LIPOPROTEINS, LDL; LIPOSOMES; MALE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; OXIDATION-REDUCTION; PHOSPHATIDYLSERINES; THROMBASTHENIA;

EID: 0033951088     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00179-6     Document Type: Article

References (36)

1. McGregor J.L., Catimel B., Parmentier S., Clezardin P., Dechavanne M., Leung L.L. Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem. 264:1989;501-506.
2. Talle M.A., Rao P.E., Westberg E., Allegar N., Makowski M., Mittler R.S., Goldstein G. Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell Immunol. 78:1983;83-99.
3. Swerlick R.A., Lee K.H., Wick T.M., Lawley T.J. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol. 148:1992;78-83.
4. Abumrad N.A., el M.M., Amri E.Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem. 268:1993;17665-17668.
5. Asch A.S., Barnwell J., Silverstein R.L., Nachman R.L. Isolation of the thrombospondin membrane receptor. J Clin Invest. 79:1987;1054-1061.
6. Kieffer N., Nurden A.T., Hasitz M., Titeux M., Breton G.J. Identification of platelet membrane thrombospondin binding molecules using an anti-thrombospondin antibody. Biochem Biophys Acta. 967:1988;408-415.
7. Tandon N.N., Kralisz U., Jamieson G.A. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 264:1989;7576-7583.
8. Oquendo P., Hundt E., Lawler J., Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell. 58:1989;95-101.
9. Acton S.L., Scherer P.E., Lodish H.F., Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem. 269:1994;21003-21009.
10. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11811-11816.
11. Nozaki S., Kashiwagi H., Yamashita S., Nakagawa T., Kostner B., Tomiyama Y., Nakata A., Ishigami M., Miyagawa J., Kameda T.K., Kurata Y., Matsuzawa Y. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 96:1995;1859-1865.
12. Stanton L.W., White R.T., Bryant C.M., Protter A.A., Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem. 267:1992;22446-22451.
13. Rigotti A., Acton S.L., Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem. 270:1995;16221-16224.
14. Tanaka T., Kawamura K. Isolation of myocardial membrane long-chain fatty acid-binding protein. homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids J Mol Cell Cardiol. 27:1995;1613-1622.
15. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today. 14:1993;131-136.
16. Bevers E.M., Comfurius P., Zwaal R.F. Changes in membrane phospholipid distribution during platelet activation. Biochem Biophys Acta. 736:1983;57-66.
17. Shukla S.D., Hanahan D.J. Membrane alterations in cellular aging. susceptibility of phospholipids in density (age)-separated human erythrocytes to phospholipase A2 Arch Biochem Biophys. 214:1982;335-341.
18. Fadok V.A., Savill J.S., Haslett C., Bratton D.L., Doherty D.E., Campbell P.A., Henson P.M. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol. 149:1992;4029-4035.
19. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 148:1992;2207-2216.
20. Yamamoto N., Akamatsu N., Yamazaki H., Tanoue K. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors. Br J Haematol. 81:1992;86-92.
21. McKeown L., Vail M., Williams S., Kramer W., Hansmann K., Gralnick H. Platelet adhesion to collagen in individuals lacking glycoprotein IV. Blood. 83:1994;2866-2871.
22. Saelman E.U., Kehrel B., Hese K.M., de G.P., Sixma J.J., Nieuwenhuis H.K. Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood. 83:1994;3240-3244.
23. Kehrel B., Kronenberg A., Schwippert B., Niesing B.D., Niehues U., Tschope D., van de Loo J., Clemetson K.J. Thrombospondin binds normally to glycoprotein IIIb deficient platelets. Biochem Biophys Res Commun. 179:1991;985-991.
24. Watanabe K., Toba K., Ogawa Y., Kodama M., Hirono S., Ohkura Y., Hanawa H., Nakamura Y., Aoki Y., Fuse I., Aizawa Y., Miyajima S., Kusano Y., Nagatomo T., Hasegawa G., Naito M. Hypertrophic cardiomyopathy with type I CD36 deficiency. Jpn Circ J. 62:1998;541-542.
25. Tanaka T., Okamoto F., Sohmiya K., Kawamura K. Lack of myocardial iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality - CD36 deficiency and hypertrophic cardiomyopathy. Jpn Circ J. 61:1997;724-725.
26. Okamoto F., Tanaka T., Sohmiya K., Kawamura K. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy. Jpn Circ J. 62:1998;499-504.
27. Daviet L., Buckland R., Puente N.M., McGregor J.L. Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis. Biochem J. 305:1995;221-224.
28. Yamamoto N., Kitagawa H., Yamamoto K., Tanoue K., Yamazaki H. Calcium ions and the conformation of glycoprotein IIIa that is essential fibrinogen binding to platelets. analysis by a new monoclonal anti-GP IIIa antibody, TM83 Blood. 73:1989;1552-1560.
29. Phillips D.R. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry. 11:1972;4582-4588.
30. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
31. Yamamoto N., Akamatsu N., Sakuraba H., Yamazaki H., Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood. 83:1994;392-397.
32. Leung L.L., Li W.X., McGregor J.L., Albrecht G., Howard R.J. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem. 267:1992;18244-18250.
33. Puente N.M., Daviet L., Ninio E., McGregor J.L. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol. 16:1996;1033-1039.
34. Yamamoto N., Ikeda H., Tandon N.N., Herman J., Tomiyama Y., Mitani T., Sekiguchi S., Lipsky R., Kralisz U., Jamieson G.A. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors. Naka- platelets lack detectable GPIV (CD36) Blood. 76:1990;1698-1703.
35. Doi T., Higashino K., Kurihara Y., Wada Y., Miyazaki T., Nakamura H., Uesugi S., Imanishi T., Kawabe Y., Itakura H., Yazaki Y., Matsumoto A., Kodama T. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem. 268:1993;2126-2133.
36. Igarashi K., Kaneda M., Yamaji A., Saido T.C., Kikkawa U., Ono Y., Inoue K., Umeda M. A novel phosphatidylserine-binding peptide motif defined by an anti-idiotypic monoclonal antibody. Localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine decarboxylase. J Biol Chem. 270:1995;29075-29078.